Stone; Edwin M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stone; Edwin M..The latest application filed is for "methods for treating macular degeneration".

Company Profile

0.11.12

Stone; Edwin M. - Iowa City IA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating macular degeneration Grant 10,973,855 - Small , et al. April 13, 2	2021-04-13
Methods For Treating Macular Degeneration App 20180117091 - Small; Kent W. ; et al.	2018-05-03
Single Nucleotide Polymorphisms And Genes Associated With Age-related Macular Degeneration App 20110104154 - Clark; Abbot F. ; et al.	2011-05-05
Diagnostics and therapeutics for glaucoma Grant 7,807,355 - Clark , et al. October 5, 2	2010-10-05
Diagnostics and Therapeutics For Glaucoma App 20090226425 - Clark; Abbot F. ; et al.	2009-09-10
Diagnostics and therapeutics for glaucoma App 20060216732 - Clark; Abbot F. ; et al.	2006-09-28
Identification of a gene causing the most common form of Bardet-Biedl syndrome and uses thereof App 20060110761 - Sheffield; Val C. ; et al.	2006-05-25
Bardet-biedl susceptibility gene and uses thereof Grant 7,045,317 - Sheffield , et al. May 16, 2	2006-05-16
Diagnostics and therapeutics for glaucoma Grant 7,033,755 - Clark , et al. April 25, 2	2006-04-25
Identification of a gene causing the most common form of bardet-biedl syndrome and uses thereof Grant 6,962,788 - Sheffield , et al. November 8, 2	2005-11-08
Glaucoma therapeutics and diagnostics Grant 6,956,103 - Stone , et al. October 18, 2	2005-10-18
Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor App 20050164256 - Sheffield, Val C. ; et al.	2005-07-28
Glaucoma therapeutics and diagnostics App 20050123960 - Stone, Edwin M. ; et al.	2005-06-09
Macular degeneration diagnostics and therapeutics App 20050059010 - Stone, Edwin M. ; et al.	2005-03-17
Methods to identify modulators of FKHL7 DNA-binding activity Grant 6,833,239 - Sheffield , et al. December 21, 2	2004-12-21
Identification of a gene causing the most common form of Bardet-Biedl Syndrome and uses thereof App 20030232375 - Sheffield, Val C. ; et al.	2003-12-18
Bardet-biedl susceptibility gene and uses thereof App 20030170645 - Sheffield, Val C. ; et al.	2003-09-11
Macular degeneration diagnostics and therapeutics App 20030138798 - Stone, Edwin M. ; et al.	2003-07-24
Macular degeneration diagnostics and therapeutics Grant 6,593,104 - Stone , et al. July 15, 2	2003-07-15
Glaucoma therapeutics and diagnostics App 20030077587 - Stone, Edwin M. ; et al.	2003-04-24
Macular degeneration diagnostics and therapeutics Grant 6,417,342 - Stone , et al. July 9, 2	2002-07-09
Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor Grant 6,087,107 - Sheffield , et al. July 11, 2	2000-07-11
Glaucoma compositions and therapeutic and diagnositic uses therefor Grant 5,885,776 - Stone , et al. March 23, 1	1999-03-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.